Skip to main content
. 2021 Dec 13;8:780605. doi: 10.3389/fcvm.2021.780605

Table 2.

Concomitant medications.

Medications Clopidogrel n = 20 Prasugrel
n = 15
Ticagrelor
n = 21
P
ASA, n (%) 20 (100%) 15 (100%) 21 (100%) 1
ACE-inhibitor, n (%) 14 (70%) 9 (60%) 15 (71%) 0.745
ß-Blocker, n (%) 16 (80%) 9 (60%) 19 (90%) 0.283
AT-1-Antagonist, n (%) 5 (25%) 6 (40%) 7 (33%) 0.130
Ca2+-Antagonist, n (%) 4 (20%) 4 (27%) 5 (24%) 0.063
Renin inhibitor,
n (%)
1 (5%) 1 (7%) 0 (0%) 0.151
Statins/
Other anti HLP, n (%)
16 (80%)/4 (20%) 14 (93%)/
1 (7%)
16 (76%)/2 (10%) 0.294
Diuretics, n (%) 11 (55%) 7 (47%) 7 (34%) 0.185
PPIs, n (%) 10 (50%) 3 (20%) 7 (33%) 0.241
L-Thyroxin, n (%) 2 (10%) 1 (7%) 3 (14%) 0.100